Delivery Order SPE2DB20D3303-SPE2DB25FA4GA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,554.70 to AmerisourceBergen Drug Corp for Bromfenac Sodium 0.09% eye drops (1.7 mL units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply delivery under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7ml units, with a ceiling value of $1,873.23. This non-competitive, firm fixed price delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Bromfenac Sodium 0.09% eye drops (1.7 mL) with a ceiling value of $7,904.95. This firm fixed-price delivery order is non-competitive and represents a single pharmaceutical product delivery to support federal medical supply needs. The contract is set to reach ultimate completion by August 13, 2025, with performance conducted from the contractor's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $9,139.92 to AmerisourceBergen Drug Corp for the supply of Bromfenac Sodium 0.09% eye drops (1.7mL units). This firm fixed-price delivery order, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award was made through open competition with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7mL units, with a contract ceiling value of $9,699.75. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of May 21, 2025. The delivery order is a child contract issued under AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $5,626.85 firm fixed price delivery order is for the supply of Bromfenac Sodium 0.09% eye drops, with a completion date of March 15, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as a prime contractor...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7 ml containers. The contract has a ceiling value of $1,714.13 and a performance period ending on July 7, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Bromfenac Sodium 0.09% eye drops. This $1,488.72 contract has a performance period through March 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The award is for the provision of Bromfenac Sodium 0.09% Eye Drops in 1.7ml containers, with a total ceiling value of $1,131.37 and a period of performance through March 12, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bromfenac Sodium 0.09% eye drops, a pharmaceutical product, with a ceiling value of $2,695.47 and a period of performance ending on November 15, 2024. The contract is not designated as a set-aside and represents an individual delivery order issued under a larger Indefinite Delivery Contract...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA4GADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7 mL units, with a ceiling value of $1,069.74. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete successfully in open federal procurement for pharmaceutical products. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs and other federal health systems worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its role as a critical pharmaceutical distributor for the Defense Logistics Agency's medical supply chain, supporting military and veteran healthcare procurement across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/26/25 |